Sedana Medical AB’s Year-end report 2022
Fast track designation in the US and our strongest quarter in 2022Fourth quarter 2022 · Net sales for the quarter totalled MSEK 35.8 (46.4), equivalent to a decrease of 23% compared to 2021. At constant exchange rates, sales decreased by 28%. · Gross profit was MSEK 25.7 (32.8) equivalent to a margin of 72% (71%). · Earnings before interest, taxes, depreciation and amortisation (EBITDA) totalled MSEK -17.6 (-13.5), equivalent to an EBITDA margin of -49% (-29%). · Operating income (EBIT) totalled MSEK -23.2 (-18.7), equivalent to an EBIT margin of -65% (-40%). · Net income